Ogungbenro K - Search Results

1

Application of optimal design methodologies in clinical pharmacology experiments.

Ogungbenro K, Dokoumetzidis A, Aarons L. Ogungbenro K, et al. Pharm Stat. 2009 Jul-Sep;8(3):239-52. doi: 10.1002/pst.354. Pharm Stat. 2009. PMID: 19009585 Review.

2

Covariates in population pharmacokinetic studies of critically ill adults receiving β-lactam antimicrobials: a systematic review and narrative synthesis.

Hansel J, Mannan F, Robey R, Kumarendran M, Bladon S, Mathioudakis AG, Ogungbenro K, Dark P, Felton TW. Hansel J, et al. Among authors: ogungbenro k. JAC Antimicrob Resist. 2024 Feb 26;6(1):dlae030. doi: 10.1093/jacamr/dlae030. eCollection 2024 Feb. JAC Antimicrob Resist. 2024. PMID: 38410250 Free PMC article. Review.

3

The use of a modified Fedorov exchange algorithm to optimise sampling times for population pharmacokinetic experiments.

Ogungbenro K, Graham G, Gueorguieva I, Aarons L. Ogungbenro K, et al. Comput Methods Programs Biomed. 2005 Nov;80(2):115-25. doi: 10.1016/j.cmpb.2005.07.001. Epub 2005 Aug 31. Comput Methods Programs Biomed. 2005. PMID: 16139390

4

Optimal blood sampling time windows for parameter estimation using a population approach: design of a phase II clinical trial.

Chenel M, Ogungbenro K, Duval V, Laveille C, Jochemsen R, Aarons L. Chenel M, et al. Among authors: ogungbenro k. J Pharmacokinet Pharmacodyn. 2005 Dec;32(5-6):737-56. doi: 10.1007/s10928-005-0014-6. J Pharmacokinet Pharmacodyn. 2005. PMID: 16341474

5

Optimal design for multivariate response pharmacokinetic models.

Gueorguieva I, Aarons L, Ogungbenro K, Jorga KM, Rodgers T, Rowland M. Gueorguieva I, et al. Among authors: ogungbenro k. J Pharmacokinet Pharmacodyn. 2006 Apr;33(2):97-124. doi: 10.1007/s10928-006-9009-1. Epub 2006 Mar 21. J Pharmacokinet Pharmacodyn. 2006. PMID: 16550455

6

Sample size calculations based on generalized estimating equations for population pharmacokinetic experiments.

Ogungbenro K, Aarons L, Graham G. Ogungbenro K, et al. J Biopharm Stat. 2006;16(2):135-50. doi: 10.1080/10543400500508705. J Biopharm Stat. 2006. PMID: 16584063

7

Optimal design for multiresponse pharmacokinetic-pharmacodynamic models - dealing with unbalanced designs.

Ogungbenro K, Gueorguieva I, Majid O, Graham G, Aarons L. Ogungbenro K, et al. J Pharmacokinet Pharmacodyn. 2007 Jun;34(3):313-31. doi: 10.1007/s10928-006-9048-7. Epub 2007 Feb 7. J Pharmacokinet Pharmacodyn. 2007. PMID: 17285361

8

A program for individual and population optimal design for univariate and multivariate response pharmacokinetic-pharmacodynamic models.

Gueorguieva I, Ogungbenro K, Graham G, Glatt S, Aarons L. Gueorguieva I, et al. Among authors: ogungbenro k. Comput Methods Programs Biomed. 2007 Apr;86(1):51-61. doi: 10.1016/j.cmpb.2007.01.004. Epub 2007 Feb 9. Comput Methods Programs Biomed. 2007. PMID: 17292995

9

Design of population pharmacokinetic experiments using prior information.

Ogungbenro K, Aarons L. Ogungbenro K, et al. Xenobiotica. 2007 Oct-Nov;37(10-11):1311-30. doi: 10.1080/00498250701553315. Xenobiotica. 2007. PMID: 17968747 Review.

10

Incorporating correlation in interindividual variability for the optimal design of multiresponse pharmacokinetic experiments.

Ogungbenro K, Graham G, Gueorguieva I, Aarons L. Ogungbenro K, et al. J Biopharm Stat. 2008;18(2):342-58. doi: 10.1080/10543400701697208. J Biopharm Stat. 2008. PMID: 18327725

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

100 results

Search Page